Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma
10.4174/astr.2022.103.4.183
- Author:
Sang Eun NAM
1
;
TongYi JIN
;
Kyoung Sik PARK
;
Madhuri SAINDANE
;
Woo Chul NOH
;
Young Bum YOO
;
Won Seo PARK
;
Ik Jin YUN
Author Information
1. Department of Surgery, Konkuk University School of Medicine, Seoul, Korea
- Publication Type:ORIGINAL ARTICLE
- From:Annals of Surgical Treatment and Research
2022;103(4):183-194
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The prognostic value of vitamin D receptor gene (VDR) expression in breast cancer development is unclear. Here, we aimed to investigate whether VDR expression can be used as a prognostic indicator of breast cancer.
Methods:We used various public bioinformatics platforms: Oncomine, GEPIA, UALCAN, Kaplan-Meier plotter, UCSC XENA, bc-GenExMiner, WebGestalt, and STRING database.
Results:We found that VDR was upregulated in breast cancer in comparison to normal tissues. Overexpression of VDR was significantly associated with worse overall survival in breast cancer. The expression of VDR was related to age, TNM stages, estrogen receptor status, progesterone receptor status, human epidermal growth factor receptor 2 status, basallike (PAM 50) status, triple-negative breast cancer (TNBC) status, and basal-like (PAM 50) & TNBC status (P < 0.05). Increased VDR expression in breast cancer was significantly associated with older age. The 5 hub genes for VDR were NCOA1, EP300, CREBBP, and RXRA.
Conclusion:Our investigation offers hints about the prognostic role of VDR in breast cancer. The findings suggest that VDR expression might be used as a marker to determine a breast cancer patient’s prognosis. Nevertheless, further validation is warranted.
